EBV-positive primary CNS lymphoma restricted to the conus medullaris in an immunocompetent host
- PMID: 32042476
- PMCID: PMC6927448
- DOI: 10.1212/CPJ.0000000000000621
EBV-positive primary CNS lymphoma restricted to the conus medullaris in an immunocompetent host
Figures

Similar articles
-
Nocardia cyriacigeorgica abscess of the conus medullaris in an immunocompetent host.J Clin Neurosci. 2010 Sep;17(9):1194-5. doi: 10.1016/j.jocn.2009.12.022. J Clin Neurosci. 2010. PMID: 20700949
-
Level of conus medullaris in term and preterm neonates.Arch Dis Child Fetal Neonatal Ed. 1997 Jul;77(1):F67-9. doi: 10.1136/fn.77.1.f67. Arch Dis Child Fetal Neonatal Ed. 1997. PMID: 9279188 Free PMC article.
-
Localization of the fetal conus medullaris by oblique view extended imaging.J Med Ultrason (2001). 2017 Oct;44(4):281-287. doi: 10.1007/s10396-017-0773-x. Epub 2017 Feb 21. J Med Ultrason (2001). 2017. PMID: 28224306
-
[Syringomyelia, scoliosis and idiopathic Arnold-Chiari malformations: a common etiology].Rev Neurol. 1996 Aug;24(132):937-59. Rev Neurol. 1996. PMID: 8755356 Review. Spanish.
-
Primary central nervous system lymphomas and related diseases: Pathological characteristics and discussion of the differential diagnosis.Neuropathology. 2016 Aug;36(4):313-24. doi: 10.1111/neup.12276. Epub 2015 Nov 26. Neuropathology. 2016. PMID: 26607855 Review.
References
-
- Flanagan EP, O'Neill BP, Porter AB, Lanzino G, Haberman TM, Keegan BM. Primary intramedullary spinal cord lymphoma. Neurology 2011;77:784–791. - PubMed
-
- Guzey FK, Hitay Y, Isler C, et al. . Primary spinal intramedullary lymphoma: a case report and review of the literature. JSM Neurosurg Spine 2015;3:1049.
-
- Sugita Y, Terasaki M, Niino D, et al. . Epstein-Barr virus-associated primary central nervous system lymphomas in immunocompetent elderly patients: analysis for latent membrane protein-1 oncogene deletion and EBNA-2 strain typing. J Neurooncol 2010;100:271–279. - PubMed
-
- Ferreri AJM, Cwynarski K, Pulczynski E, et al. . Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. Lancet Haematol 2016;3:e217–e227. - PubMed
Publication types
LinkOut - more resources
Full Text Sources